Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138


Engineering HIV-Resistant, Anti-HIV Chimeric Antigen Receptor T Cells.

Hale M, Mesojednik T, Romano Ibarra GS, Sahni J, Bernard A, Sommer K, Scharenberg AM, Rawlings DJ, Wagner TA.

Mol Ther. 2017 Mar 1;25(3):570-579. doi: 10.1016/j.ymthe.2016.12.023. Epub 2017 Jan 28.


Combining Cell and Gene Therapy in an Effort to Eradicate HIV.

Wagner TA.

AIDS Patient Care STDS. 2016 Dec;30(12):534-538.


Possible involvement of distinct phylogenetic clusters of HIV-1 variants in the discrepancies between coreceptor tropism predictions based on viral RNA and proviral DNA.

Kotani H, Sudo K, Hasegawa N, Fujiwara H, Hayakawa T, Iketani O, Yamaguchi M, Mochizuki M, Iwata S, Kato S.

J Pharm Health Care Sci. 2016 Nov 9;2:31. eCollection 2016.


Multi-dose Romidepsin Reactivates Replication Competent SIV in Post-antiretroviral Rhesus Macaque Controllers.

Policicchio BB, Xu C, Brocca-Cofano E, Raehtz KD, He T, Ma D, Li H, Sivanandham R, Haret-Richter GS, Dunsmore T, Trichel A, Mellors JW, Hahn BH, Shaw GM, Ribeiro RM, Pandrea I, Apetrei C.

PLoS Pathog. 2016 Sep 15;12(9):e1005879. doi: 10.1371/journal.ppat.1005879. eCollection 2016 Sep.


Total HIV-1 DNA, a Marker of Viral Reservoir Dynamics with Clinical Implications.

Avettand-Fènoël V, Hocqueloux L, Ghosn J, Cheret A, Frange P, Melard A, Viard JP, Rouzioux C.

Clin Microbiol Rev. 2016 Oct;29(4):859-80. doi: 10.1128/CMR.00015-16. Review.


Long noncoding RNA NRON contributes to HIV-1 latency by specifically inducing tat protein degradation.

Li J, Chen C, Ma X, Geng G, Liu B, Zhang Y, Zhang S, Zhong F, Liu C, Yin Y, Cai W, Zhang H.

Nat Commun. 2016 Jun 13;7:11730. doi: 10.1038/ncomms11730.


Persistent HIV-1 replication maintains the tissue reservoir during therapy.

Lorenzo-Redondo R, Fryer HR, Bedford T, Kim EY, Archer J, Kosakovsky Pond SL, Chung YS, Penugonda S, Chipman JG, Fletcher CV, Schacker TW, Malim MH, Rambaut A, Haase AT, McLean AR, Wolinsky SM.

Nature. 2016 Feb 4;530(7588):51-6. doi: 10.1038/nature16933. Epub 2016 Jan 27.


A Subset of CD4/CD8 Double-Negative T Cells Expresses HIV Proteins in Patients on Antiretroviral Therapy.

DeMaster LK, Liu X, VanBelzen DJ, Trinité B, Zheng L, Agosto LM, Migueles SA, Connors M, Sambucetti L, Levy DN, Pasternak AO, O'Doherty U.

J Virol. 2015 Nov 4;90(5):2165-79. doi: 10.1128/JVI.01913-15.


A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals.

Procopio FA, Fromentin R, Kulpa DA, Brehm JH, Bebin AG, Strain MC, Richman DD, O'Doherty U, Palmer S, Hecht FM, Hoh R, Barnard RJ, Miller MD, Hazuda DJ, Deeks SG, Sékaly RP, Chomont N.

EBioMedicine. 2015 Jun 27;2(8):874-83. doi: 10.1016/j.ebiom.2015.06.019. eCollection 2015 Aug.


Increased cardiovascular disease risk in the HIV-positive population on ART: potential role of HIV-Nef and Tat.

Wang T, Yi R, Green LA, Chelvanambi S, Seimetz M, Clauss M.

Cardiovasc Pathol. 2015 Sep-Oct;24(5):279-82. doi: 10.1016/j.carpath.2015.07.001. Epub 2015 Jul 9. Review.


Plasmacytoid dendritic cell and functional HIV Gag p55-specific T cells before treatment interruption can inform set-point plasma HIV viral load after treatment interruption in chronically suppressed HIV-1(+) patients.

Papasavvas E, Foulkes A, Yin X, Joseph J, Ross B, Azzoni L, Kostman JR, Mounzer K, Shull J, Montaner LJ.

Immunology. 2015 Jul;145(3):380-90. doi: 10.1111/imm.12452. Epub 2015 May 19.


Changes in HIV reservoirs during long-term antiretroviral therapy.

Hong FF, Mellors JW.

Curr Opin HIV AIDS. 2015 Jan;10(1):43-8. doi: 10.1097/COH.0000000000000119. Review.


Quantifying the turnover of transcriptional subclasses of HIV-1-infected cells.

Althaus CL, Joos B, Perelson AS, Günthard HF.

PLoS Comput Biol. 2014 Oct 23;10(10):e1003871. doi: 10.1371/journal.pcbi.1003871. eCollection 2014 Oct.


Identification and characterization of HIV-1 latent viral reservoirs in peripheral blood.

Chargin A, Yin F, Song M, Subramaniam S, Knutson G, Patterson BK.

J Clin Microbiol. 2015 Jan;53(1):60-6. doi: 10.1128/JCM.02539-14. Epub 2014 Oct 22.


Healthy HIV-1-infected individuals on highly active antiretroviral therapy harbor HIV-1 in their alveolar macrophages.

Cribbs SK, Lennox J, Caliendo AM, Brown LA, Guidot DM.

AIDS Res Hum Retroviruses. 2015 Jan;31(1):64-70. doi: 10.1089/AID.2014.0133.


Monocytes as regulators of inflammation and HIV-related comorbidities during cART.

Anzinger JJ, Butterfield TR, Angelovich TA, Crowe SM, Palmer CS.

J Immunol Res. 2014;2014:569819. doi: 10.1155/2014/569819. Epub 2014 Jun 12. Review.


Monocytes mediate HIV neuropathogenesis: mechanisms that contribute to HIV associated neurocognitive disorders.

Williams DW, Veenstra M, Gaskill PJ, Morgello S, Calderon TM, Berman JW.

Curr HIV Res. 2014;12(2):85-96. Review.


Effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women.

Ngemu EK, Khayeka-Wandabwa C, Kweka EJ, Choge JK, Anino E, Oyoo-Okoth E.

BMC Res Notes. 2014 Jan 21;7:52. doi: 10.1186/1756-0500-7-52. Retraction in: BMC Res Notes. 2014;7:868.


Successful isolation of infectious and high titer human monocyte-derived HIV-1 from two subjects with discontinued therapy.

Wang T, Xu Y, Zhu H, Andrus T, Ivanov SB, Pan C, Dolores J, Dann GC, Zhou M, Forte D, Yang Z, Holte S, Corey L, Zhu T.

PLoS One. 2013 May 31;8(5):e65071. doi: 10.1371/journal.pone.0065071. Print 2013.

Supplemental Content

Support Center